Clinical Services Unit
Pharmaceutical Sciences
                                                    Vancouver Acute

• November 2000 (Vol 7, No.4)  Acetylcysteine via nebulizer, Glycoprotein GIIb/IIIa antagonists (eptifibatide & tirofiban) for acute coronary syndromes, Ketorolac injectable for donor nephrectomy, Infusion Program IV Resource Nurse Consult service.
• August 2000 (Vol7, No.3)  Levofloxacin, Enoxaparin for Acute Coronary Syndromes. (89 kb PDF file)

  Enoxaparin for Acute Coronary Syndromes
  Payel Patel, Pharm.D. Student, Rubina Sunderji, Pharm.D., FCSHP

  Levofloxacin (LevaquinÒ): A New Formulary Addition for Community-Acquired Pneumonia
  Sean Gorman, Pharm.D. Student, Manjoyt Randhawa, Pharm.D. Student (Reviewed by the members of the Antibiotic Use Subcommittee (G Stiver, PJ Jewesson, B Bowie, E Bryce, A Chow, F Marra, T Nevill)

   

• June 2000 (Vol 7, No. 2) Donepezil, Clopidogrel safety update, Patients’ Perceptions about Substitution of a Reference Drug while in Hospital, Drugs of Current Interest (101 kb PDF file)
• February 2000 (Vol 7, No.1)  Bupropion SR, Piperacillin/Tazobactam, 1999 Adverse Drug Reaction Reports, Alteplase for occcluded venous catheters, ACE-Inhibitor interchange policy
• November 1999 (Vol 6, No.4) New warfarin consultation service, Revised Reserved Antimicrobial Drug policy, Infusion program updates, Removal of nifedipine from wards. (101kb .pdf file)

  Infusion Program Update - November 1999
  The Vancouver Hospital Infusion Program

• August 1999 (Vol 6, No.3)  Revised PTT Range for Heparin Protocol, New susceptibility testing for Staphylococci, VGH/UBCH 1999 Formularies, Cisapride drug interactions, Losartan, Milrinone (75kb .pdf file)
  
• May 1999 (Vol 6, No.2)  Clopidogrel, Terazosin, H.pylori eradication regimen changes, Warfarin/Herb interactions, Grapefruit juice interactions, Infusion Program updates. (121kb .pdf)

  Grapefruit Juice-Medication Interactions
  Karen Shalansky, Pharm.D.

  Herbal Interactions with Warfarin
  Mario de Lemos, Pharm. D. student, Rubina Sunderji, Pharm.D.

  Clopidogrel
  Mario de Lemos, Pharm.D. student, Rubina Sunderji, Pharm.D

• February 1999 (Vol 6, No.1) Cefamandole interchange, Amoxicillin/Clavulanic Acid, Racemic Epinephrine, CSU - Pharmaceutical Sciences Awards, Prophylaxis for PONV, Infusion Program update, Adverse drug reactions 1998. (103kb .pdf)

  Amoxicillin/Clavulanate (Clavulin®)
  Carlo Marra, Pharm.D., Luciana Frighetto, B.Sc. (Pharm)

  Antiemetic Prophylaxis for Post-Operative Nausea and Vomiting
  Luciana Frighetto, B.Sc. (Pharm), Carlo Marra, Pharm.D., Peter Loewen, Pharm.D.

  Adverse Drug Reaction Reports 1998
  VH CSU-Pharmaceutical Sciences

  Infusion Program Update - February 1999
  The Vancouver Hospital Infusion Program

• December 1998 (Vol 5, No.4) Simvastatin, TPN prescribing privileges, infusion program updates, medication administration by respiratory technicians. (78kb PDF file)

  HMG-CoA Reductase Inhibitor ("Statin") Interchange to Simvastatin
  Emily Chan, B.Sc. (Pharm),  Rubina Sunderji, Pharm.D., Karen Shalansky, Pharm.D.

  Infusion Program Update - December 1998
  The Vancouver Hospital Infusion Program

• September 1998 (Vol 5, No.3) Topiramate, Infusion Program Updates, Outpatient self-management of Warfarin study. (71kb pdf file)

  Topiramate: A new anticonvulsant
  Karen Shalansky, Pharm.D., Saira Alladina, B.Sc. (Pharm)

  Infusion Program Updates - September 1998
  The VH Infusion Program Team

• May 1998 (Vol 5, No.2) Fexofenadine, Hypertensive urgencies, Tolcapone, Digibind prescribing, Aminoglycoside/Vancomycin level draw times, Fluticasone / Beclomethasone interchange, Clinical clerk prescribing.

  Fexofenadine (Allegra®): A new H1 Antagonist
  Karen Shalansky, Pharm.D.

  Hypertensive Urgencies : No Role for Nifedipine
  Marie-France Beauchesne, Pharm.D. Candidate,
  Rubina Sunderji, Pharm.D., Karen Shalansky, Pharm.D.

  Tolcapone (Tasmar®) for Parkinson's Disease
  Niloofar Alikashani, Pharmacy Resident, Alan Low, Pharm.D.

• February 1998 (Vol 5, No.1) Dolasetron, remifentanyl, 1997 adverse drug reactions, danaparoid, pharmaceutical industry representative guidelines.

  Danaparoid for Heparin-Induced Thrombocytopenia
  Karen Shalansky, Pharm.D.

• December 1997 (Vol 4, No.4) Ceftriaxone/ceftazidime IV-IV Stepdown, Home IV Antibiotic Program Update (391K PDF file)

  Home IV Antibiotic Program: A Two Year Update
  Amy Wai, B.Sc. (Pharm)
  VHHSC Home IV Antibiotic Program

  Ceftriaxone and Ceftazidime IV-IV Dosage Stepdown Initiative
  Amy Wai, B.Sc. (Pharm)
  VHHSC Home IV Antibiotic Program

• September 1997 (Vol 4, No.3) Olanzapine & Bone Marrow Suppression Update, Clodronate, Low Molecular Weight Heparins for DVT Prophylaxis (315K PDF file)

  Low-Molecular Weight Heparins for DVT Prophylaxis in Orthopedic Patients
  Zahra Esmail, Pharm.D. Student, Rubina Sunderji, Pharm.D.

• June 1997  (Vol 4, No.2) Olanzapine, Treatment of H.pylori at VHHSC, Phenytoin & Folic acid drug interaction.  (484K pdf file, or 342K Zipped PDF file)

  Treatment of Helicobacter pylori in association with Peptic Ulcer Disease
  Dr. K. Shalansky, C. Hughes, Dr. P. Loewen

• March 1997 (Vol 4, No.1)  Ramipril, Zopiclone, Treatment of Infected Pacemaker Pockets, Ondansetron for Post-Operative Nausea and Vomiting, 1996 Adverse Drug Reactions Summary (64k pdf file)
• December 1996 (Vol 3, No.4) Cisapride and QT-prolongation, Fenluramine and primary pulmonary hypertension, Revised drug administration policies. (47 kb pdf file)
• September 1996 (Vol 3, No.3) Tinzaparin for DVT treatment,  Nefazodone & Venlafaxine for refractory depression (69 kb pdf file).
• May 1996  The calcium channel blocker controversy. (64kb pdf file)
• March 1996 (Vol 3, No.1) Research awards, Role of methadone in chronic cancer pain, Cotrimoxazole-induced hyperkalemia, Adverse drug reaction reports in 1995. (84 kb pdf file)
• December 1995  (Vol 2, No.6) Pentasa, New anticonvulsants (gabapentin, lamotrigine, vigabatrin), Warfarin dosing program, Sotalol-induced Torsades de Pointes (90 kb pdf file)
• September 1995  (Vol 2, No.5) Home IV antibiotic program, Calcium salts as phosphate binders, oxtriphylline conversion to Theodur, Unusually high INR's with warfarin. (77kb pdf file).
• July 1995  (Vol 2, No.4) Oral meperidine interchange with oral morphine, Sumatriptan cross-sensitivity with sulfonamides, SSRI abrupt withdrawal syndrome. (78 kb pdf file)
• June 1995 (Vol 2, Supplement A, No.3) - Modified Aminoglycoside Dosing (eg. once-daily). (142 kb pdf file)

Many documents on this page are in Adobe Acrobat's PDF (portable document format) so they can be viewed and printed on any platform (DOS/Windows/Unix/Mac).  This requires that you have the Adobe Acrobat Viewer program on your computer.  The viewer is FREE and can be downloaded from Adobe Systems Corp.'s Acrobat page.